{"adverse_reactions":["Adverse Reactions"],"animal_pharmacology_and_or_toxicology":["animal Pharmacology/Toxicology"],"carcinogenesis_and_mutagenesis_and_impairment_of_fertility":["Carcinogenesis"],"clinical_pharmacology":["Clinical Pharmacology"],"contraindications":["Contraindications"],"description":["Description"],"dosage_and_administration":["Dosage and Administration Adults and children Infants and newborns"],"drug_and_or_laboratory_test_interactions":["Drug-Laboratory Interactions"],"drug_interactions":["Drug Interactions"],"effective_time":"20230105","how_supplied":["how supplied"],"id":"f1863e5d-f2b6-2e47-e053-2a95a90af475","indications_and_usage":["Indications and Usage"],"information_for_patients":["Information for patients"],"labor_and_delivery":["labor and deliver"],"laboratory_tests":["Laboratory Tests"],"nonteratogenic_effects":["Non Terotogenic effects"],"nursing_mothers":["Nursing Mothers"],"openfda":{},"overdosage":["Overdosage"],"package_label_principal_display_panel":["primary package label-bottle","primary package label-carton"],"pediatric_use":["Pediatric Use"],"precautions":["Precautions precautions 2"],"pregnancy":["pregnancy"],"set_id":"f1863e5d-f2b5-2e47-e053-2a95a90af475","spl_product_data_elements":["Diazoxide Oral Solution Diazoxide Oral Suspension METHYLPARABEN MAGNESIUM ALUMINUM SILICATE SODIUM BENZOATE CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 100-200 MPA.S AT 1%) PROPYLENE OXIDE SORBITOL SOLUTION 70% ALCOHOL DIAZOXIDE DIAZOXIDE PROPYLENE GLYCOL, (R)- HYDROCHLORIC ACID PROPYLPARABEN"],"version":"1","warnings":["Warnings"]}